Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Measurable residual disease monitoring in AML: Prospects for therapeutic decision‐making and new drug development

American Journal of Hematology(2024)10.1002/ajh.27482Source: DataRank Database

Measurable residual disease monitoring in AML: Prospects for therapeutic decision‐making and new drug development is a research paper published in American Journal of Hematology (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.64)OA: bronzeTopics (26)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Richard Dillon ORCID,Nicholas J. Short ORCID

Live enrichment

PubMed:39319951 PMC:PMC11832336 OpenAlex:https://openalex.org/W4402847775

Blood Cancer UK

Grant: 21008

Cancer Research UK

Grant: 29806

NCI NIH HHS

Grant: P30 CA016672

FWCI

3.64

Citation Percentile

0.9%

Citation Trend

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.27482

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.27482

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27482

journalhttps://doi.org/10.1002/ajh.27482

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39319951

Fields of Study

Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationHistone Deacetylase Inhibitors ResearchHumansNeoplasm, ResidualLeukemia, Myeloid, AcuteDrug DevelopmentClinical Decision-MakingPrognosis

MeSH Terms

Clinical Decision-MakingDrug DevelopmentHumansPrognosisLeukemia, Myeloid, AcuteNeoplasm, ResidualHematopoietic Stem Cell Transplantation

Keywords

MedicineMinimal residual diseaseCandidacyOncologyClinical trialIntensive care medicineDiseaseMyeloid leukemiaInternal medicineLeukemia

Sustainable Development Goals

SDG 0: Good health and well-being